Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › UT › LAYTON › DAVIS HOSPITAL & MEDICAL CENTER LP

DAVIS HOSPITAL & MEDICAL CENTER LP

NPI: 1548205818 · LAYTON, UT 84041 · General Acute Care Hospital · NPI assigned 06/19/2006

$22.49M
Total Medicaid Paid
417,491
Total Claims
309,232
Beneficiaries
209
Codes Billed
2018-01
First Month
2023-11
Last Month

Provider Details

Authorized OfficialJENSEN, MICHAEL (HOSPITAL CEO)
NPI Enumeration Date06/19/2006

Related Entities

Other providers sharing the same authorized official: JENSEN, MICHAEL

ProviderCityStateTotal Paid
UTAH NAVAJO HEALTH SYSTEM, INCORPORATED MONTEZUMA CREEK UT $15.67M
UTAH NAVAJO HEALTH SYSTEM, INCORPORATED BLANDING UT $2.54M
UTAH NAVAJO HEALTH SYSTEM, INCORPORATED MONUMENT VALLEY UT $1.79M
US HOMEMED, LLC MANASQUAN NJ $755K
UTAH NAVAJO HEALTH SYSTEM, INCORPOARTED BLANDING UT $151K
UTAH NAVAJO HEALTH SYSTEM, INCORPORATED NAVAJO MOUNTAIN UT $93K
FRONTIER PHYSICAL THERAPY PC GREAT FALLS MT $32K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 80,508 $3.78M
2019 77,129 $3.58M
2020 73,985 $4.35M
2021 96,343 $5.56M
2022 84,739 $5.02M
2023 4,787 $195K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
8888888 Internal/system code - not a standard HCPCS code 59,028 19,982 $15.87M
36415 Collection of venous blood by venipuncture 27,979 21,621 $3.26M
99283 Emergency department visit for the evaluation and management, moderate severity 14,305 12,777 $432K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,613 1,465 $269K
J7060 5% dextrose/water (500 ml = 1 unit) 414 352 $198K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,018 3,404 $184K
99284 Emergency department visit for the evaluation and management, high severity 14,210 12,333 $171K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2,487 2,321 $126K
70450 Computed tomography, head or brain; without contrast material 2,601 2,331 $111K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 10,933 9,097 $100K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 10,672 9,044 $84K
71046 Radiologic examination, chest; 2 views 2,468 2,277 $81K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 802 745 $80K
71045 Radiologic examination, chest; single view 5,013 4,375 $69K
87400 1,103 1,026 $66K
96361 Intravenous infusion, hydration; each additional hour 5,960 5,064 $61K
81001 8,054 6,896 $60K
81003 5,088 4,440 $58K
82962 2,093 1,359 $54K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,019 937 $51K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,145 987 $50K
87070 1,065 907 $47K
73610 539 482 $44K
99281 Emergency department visit for the evaluation and management, self-limited or minor 684 641 $38K
73630 652 582 $37K
87081 1,166 1,072 $34K
73562 441 378 $33K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 479 400 $33K
80053 Comprehensive metabolic panel 16,819 13,584 $32K
84703 4,633 4,089 $31K
73110 340 302 $30K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,981 2,655 $29K
73130 303 264 $25K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3,994 1,172 $24K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 3,673 3,171 $21K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 576 534 $21K
31720 765 584 $20K
89220 375 320 $20K
87088 2,117 1,837 $19K
87486 524 457 $19K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 20,014 15,801 $19K
12001 281 256 $18K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,585 1,398 $16K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,225 1,083 $15K
C1758 Catheter, ureteral 621 520 $14K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 6,824 5,676 $14K
J7030 Infusion, normal saline solution , 1000 cc 5,469 4,238 $14K
80050 General health panel 2,642 2,376 $14K
87077 1,815 1,599 $13K
J2405 Injection, ondansetron hydrochloride, per 1 mg 9,746 7,672 $12K
87086 Culture, bacterial; quantitative colony count, urine 1,929 1,646 $12K
82947 320 226 $11K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 146 115 $11K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 433 200 $11K
73030 173 148 $10K
84443 Thyroid stimulating hormone (TSH) 2,884 2,433 $10K
72100 139 121 $10K
76705 Ultrasound, abdominal, real time with image documentation; limited 360 328 $10K
J7050 Infusion, normal saline solution, 250 cc 28 26 $10K
J1885 Injection, ketorolac tromethamine, per 15 mg 8,381 6,774 $9K
96375 Therapeutic injection; each additional sequential IV push 7,740 6,381 $9K
88305 Level IV - Surgical pathology, gross and microscopic examination 1,377 1,193 $9K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 720 679 $9K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 98 63 $8K
74176 Computed tomography, abdomen and pelvis; without contrast material 608 554 $8K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,956 3,409 $8K
99152 1,028 857 $8K
J7120 Ringers lactate infusion, up to 1000 cc 1,503 1,183 $8K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,282 1,104 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,956 1,579 $8K
J2270 Injection, morphine sulfate, up to 10 mg 3,454 2,656 $7K
71275 Computed tomographic angiography, chest, with contrast material 697 611 $7K
80081 184 164 $6K
A6222 Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 142 126 $6K
72125 Computed tomography, cervical spine; without contrast material 359 328 $6K
83690 5,992 4,995 $5K
86850 1,361 1,165 $5K
81025 1,326 1,185 $5K
J2175 Injection, meperidine hydrochloride, per 100 mg 194 163 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,522 1,331 $4K
59025 Fetal non-stress test 994 663 $4K
86592 834 730 $4K
84484 5,120 3,882 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg 2,196 1,873 $3K
12011 55 48 $3K
80048 Basic metabolic panel (calcium, ionized) 2,613 2,124 $3K
87480 63 55 $3K
87420 250 238 $3K
93971 125 116 $3K
A6402 Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing 209 181 $3K
84702 1,275 952 $3K
C1769 Guide wire 34 24 $3K
G0500 Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) 233 200 $3K
85379 1,119 999 $2K
86900 1,528 1,306 $2K
76830 Ultrasound, transvaginal 75 69 $2K
80329 860 675 $2K
T1015 Clinic visit/encounter, all-inclusive 816 255 $2K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 308 274 $2K
74018 43 40 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 1,578 467 $2K
J2060 Injection, lorazepam, 2 mg 2,195 1,723 $2K
96376 1,519 1,237 $2K
80320 1,101 985 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 341 163 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,742 1,442 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 5,548 3,972 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 2,697 2,360 $1K
94760 1,355 1,038 $1K
J1170 Injection, hydromorphone, up to 4 mg 2,528 1,762 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 206 195 $1K
85610 1,467 1,206 $1K
J3490 Unclassified drugs 306 235 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 179 170 $1K
0064U 73 62 $1K
80061 Lipid panel 1,362 1,220 $1K
77067 Screening mammography, bilateral, including computer-aided detection 15 14 $1K
97161 411 336 $1K
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 725 658 $1K
86140 749 613 $1K
87807 98 92 $1K
82805 47 24 $1K
73080 13 12 $1K
A9270 Non-covered item or service 7,582 1,968 $952.28
J0690 Injection, cefazolin sodium, 500 mg 3,081 2,035 $897.72
82550 1,009 865 $859.94
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 684 613 $833.85
J2704 Injection, propofol, 10 mg 4,658 3,937 $722.02
84439 1,200 1,049 $721.04
J0171 Injection, adrenalin, epinephrine, 0.1 mg 939 732 $692.77
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 49 42 $643.24
G0378 Hospital observation service, per hour 909 505 $629.03
80055 34 34 $628.95
83880 1,912 1,627 $609.30
76801 59 49 $519.24
82803 16 14 $501.48
J2250 Injection, midazolam hydrochloride, per 1 mg 2,319 1,984 $485.18
90714 167 158 $474.57
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 283 99 $450.94
Q0244 Injection, casirivimab and imdevimab, 1200 mg 33 22 $418.48
83605 1,330 1,114 $407.24
87205 1,039 877 $400.36
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 214 197 $388.39
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,856 1,572 $387.60
87581 214 197 $384.80
87186 2,028 1,790 $358.61
74022 16 16 $346.17
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 234 216 $343.21
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 52 34 $341.05
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 668 588 $314.79
99153 Mod sedat endo service >5yrs 723 616 $310.48
85027 1,513 1,300 $235.63
G0237 Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) 86 56 $206.19
86403 24 23 $173.24
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,544 1,346 $136.03
86762 281 237 $117.52
86593 22 18 $104.85
83036 Hemoglobin; glycosylated (A1C) 1,407 1,219 $96.88
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 124 98 $91.17
87340 629 551 $89.06
85007 681 605 $77.50
87040 934 615 $67.01
J2360 Injection, orphenadrine citrate, up to 60 mg 113 102 $52.04
87653 104 95 $51.51
83735 546 419 $48.73
80179 454 410 $24.55
80143 471 424 $24.55
82077 542 467 $23.42
94664 77 68 $22.91
86901 1,542 1,318 $21.22
86780 281 257 $12.36
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 142 110 $10.90
29125 16 15 $10.90
85730 258 224 $10.50
J2550 Injection, promethazine hcl, up to 50 mg 89 72 $6.63
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 115 87 $1.90
85651 110 75 $1.90
80159 179 134 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 479 268 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 282 234 $0.00
88313 276 252 $0.00
87260 38 34 $0.00
87660 63 55 $0.00
86703 22 22 $0.00
A4649 Surgical supply; miscellaneous 233 197 $0.00
83525 16 13 $0.00
84466 13 12 $0.00
86787 64 52 $0.00
J1644 Injection, heparin sodium, per 1000 units 104 39 $0.00
93976 70 69 $0.00
83540 13 12 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 29 25 $0.00
J3486 Injection, ziprasidone mesylate, 10 mg 22 12 $0.00
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 13 12 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 624 562 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 473 412 $0.00
82728 14 13 $0.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 57 29 $0.00
87158 63 59 $0.00
J8540 Dexamethasone, oral, 0.25 mg 34 31 $0.00
82607 29 26 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 60 48 $0.00
A9585 Injection, gadobutrol, 0.1 ml 14 12 $0.00
87510 63 55 $0.00
82553 14 12 $0.00
88304 16 14 $0.00
J1630 Injection, haloperidol, up to 5 mg 21 12 $0.00
86803 17 16 $0.00
83001 13 12 $0.00